FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$124M
1-Year Return
24.36%
This Quarter Return
-22.89%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
–
AUM
$218M
AUM Growth
-$87.2M
(-29%)
Cap. Flow
-$14.2M
Cap. Flow
% of AUM
-6.5%
Top 10 Holdings %
Top 10 Hldgs %
82.07%
Holding
26
New
5
Increased
5
Reduced
6
Closed
8
Top Buys
| 1 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
$10.5M |
| 2 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$9.45M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$4.88M |
| 4 |
CBAY
Cymabay Therapeutics
CBAY
|
$4.78M |
| 5 |
SI-BONE Inc
SIBN
|
$4.3M |
Top Sells
| 1 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$16.7M |
| 2 |
Omeros
OMER
|
$8.69M |
| 3 |
Rhythm Pharmaceuticals
RYTM
|
$7.98M |
| 4 |
Xenon Pharmaceuticals
XENE
|
$5.09M |
| 5 |
Arbutus Biopharma
ABUS
|
$4.19M |
Sector Composition
| 1 | Healthcare | 85.53% |